Request for Information - Centers for Disease Control and Prevention / National Institute of Occupational Safety and Health / World Trade Center Health Program
ID: RFI-CDC-75D301-01Type: Special Notice
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFCENTERS FOR DISEASE CONTROL AND PREVENTIONCDC OFFICE OF ACQUISITION SERVICESATLANTA, GA, 30333, USA

NAICS

All Other Outpatient Care Centers (621498)

PSC

MEDICAL- GENERAL HEALTH CARE (Q201)

Original Source

https://sam.gov/opp/233daca114144bfbb0e399124fce3032/view
Timeline
  1. 1
    Posted Jan 16, 2025, 12:00 AM UTC
  2. 2
    Updated Jan 16, 2025, 12:00 AM UTC
  3. 3
    Due Jan 31, 2025, 5:00 PM UTC
Description

The Centers for Disease Control and Prevention (CDC) is issuing a Request for Information (RFI) to gather industry feedback on a draft Performance Work Statement (PWS) related to the operation of a Survivor Clinical Center of Excellence (CCE) for individuals affected by the September 11, 2011 terrorist attacks in the New York metropolitan area. The objective of this procurement is to ensure continued health monitoring and treatment for eligible survivors, with the CDC seeking input on the clarity, completeness, and feasibility of the draft PWS to enhance the potential procurement process. This initiative is critical for providing necessary healthcare services to a vulnerable population, and the feedback received will help refine the evaluation techniques for selecting qualified vendors. Interested parties must submit their feedback to Serina Allingham at xog9@cdc.gov by 12:00 EST on January 31, 2025, and should note that this RFI is for information purposes only and does not constitute a solicitation for proposals.

Point(s) of Contact
Serina Allingham
17704484602
xog9@cdc.gov
Files
No associated files provided.
Similar Opportunities
World Trade Center Health Program - Outreach and Education
Buyer not available
The Department of Health and Human Services, through the Centers for Disease Control and Prevention (CDC), is seeking contractors for the World Trade Center Health Program's Outreach and Education services. The objective is to implement targeted outreach, education, and support services for 9/11 survivors and responders, enhancing awareness and enrollment in the program, which currently serves over 125,000 members. This initiative is crucial for addressing the long-term health impacts of the September 11 attacks, ensuring eligible individuals receive necessary medical monitoring and treatment. Interested contractors must submit proposals by the specified deadlines, with the contract expected to be awarded by June 14, 2025. For further inquiries, contact Joseph Jones at zjb2@cdc.gov.
World Trade Center Health Program Third-Party Administrator (TPA)
Buyer not available
The Department of Health and Human Services, specifically the Centers for Disease Control and Prevention (CDC), is seeking proposals for a Third-Party Administrator (TPA) to manage the World Trade Center (WTC) Health Program. The TPA will be responsible for processing enrollment applications, managing provider networks, administering medical benefits, and handling claims for individuals affected by the September 11 attacks. This program is crucial for providing healthcare services to approximately 132,000 members, ensuring they receive necessary medical monitoring and treatment for WTC-related conditions. Interested offerors must submit their proposals by April 11, 2025, with a pre-proposal conference scheduled for January 22, 2025. For further inquiries, contact Joshua Houston at jhouston@cdc.gov.
CDC DFWED NARST Sensititre Supplies
Buyer not available
The Centers for Disease Control and Prevention (CDC) is seeking to award a sole source contract for antimicrobial resistance testing supplies, specifically Sensititre™ broth microdilution testing products, from ThermoFisher Scientific. This procurement is essential for the National Antimicrobial Resistance Monitoring System (NARMS), which has utilized these proprietary materials since 1996 to ensure a standardized approach to monitoring enteric bacteria resistance. The unique nature of these supplies necessitates this sole source approach, as alternatives would require significant investments in new equipment and validation processes, potentially disrupting critical surveillance efforts. Interested parties may respond within 15 days to express their interest, with proposals directed to contract specialist Ashley Williams at dal3@cdc.gov.
DHS CWMD Mobile Detection Deployment Program (MDDP) RFI
Buyer not available
The Department of Homeland Security (DHS) is seeking sources for the Mobile Detection Deployment Program (MDDP) to enhance the nation's capabilities in detecting and responding to chemical, biological, radiological, and nuclear (CBRN) threats. The program requires deployable field management and scientific support services, including operational, technical, and logistical aid, as outlined in the attached Statement of Work (SOW). This initiative is critical for national security, ensuring preparedness against weapons of mass destruction through effective deployment and maintenance of detection assets, training personnel, and managing technical support staff. Interested vendors must submit a capability statement by April 29, 2025, and can contact William Grimm at william.grimm@hq.dhs.gov or 202-601-9823 for further information.
Vaccines for Adults
Buyer not available
The Centers for Disease Control and Prevention (CDC) is seeking to establish one or more Indefinite Delivery/Indefinite Quantity (ID/IQ) contracts for the procurement of standard commercial adult vaccines. The primary objective of this initiative is to utilize Section 317 vaccine purchase funds to provide vaccines at prices lower than those available in the commercial marketplace, specifically targeting state and local health departments to serve populations at high risk for under-vaccination. This procurement is crucial for enhancing adult immunization coverage and ensuring effective immunization practices in alignment with public health initiatives. Interested parties can contact James Sprigler at zbs6@cdc.gov or Chad Turner at ukr9@cdc.gov for further information, with the contract performance period set from July 1, 2025, to June 30, 2026.
Serological Assays for the Detection and Characterization of Influenza Viruses
Buyer not available
The Department of Health and Human Services, specifically the Centers for Disease Control and Prevention (CDC), is seeking proposals for a contract to provide serological assays for the detection and characterization of influenza viruses. The contract will involve performing hemagglutination inhibition (HAI) assays on approximately 6,000 human serum samples annually, with the potential for increased testing capacity during outbreaks, and aims to enhance influenza surveillance and vaccine effectiveness studies. This procurement is critical for bolstering public health response capabilities, ensuring high-throughput testing services, and fostering innovation in serological assay methods. Interested parties should note that the solicitation is currently suspended, and inquiries should be directed to Vic Veguilla at the CDC via email at jgartzke@cdc.gov for further information.
RFI-Cross-Domain Cybersecurity Solution
Buyer not available
The Department of Justice, specifically the Federal Bureau of Investigation (FBI), is seeking information regarding a Cross-Domain Cybersecurity Solution (CDCS) to enhance its IT infrastructure. The FBI aims to replace its current system provided by Forcepoint/Everfox with a solution that meets the NSA's "Raise the Bar" standards, capable of handling high volumes of data up to a Top-Secret level across various classified networks. This RFI is intended to gather market information on available hardware, software, and professional services, with submissions due electronically by May 2, 2025. Interested vendors should contact Meredith Mcie at mkmcie@fbi.gov for further details, noting that this solicitation is for informational purposes only and does not constitute a binding contract.
DHS CWMD Personal Radiation Detector (PRD) Maritime Variant RFI
Buyer not available
The Department of Homeland Security (DHS) is conducting a Request for Information (RFI) for Commercial Off-The-Shelf (COTS) Personal Radiation Detectors (PRDs) specifically designed for maritime applications. The DHS's Countering Weapons of Mass Destruction Office (CWMD) seeks to gather insights on the networking and data streaming capabilities of these devices, which must effectively detect gamma and neutron radiation while meeting specific performance standards outlined in the attached requirements document. This initiative is crucial for enhancing national security by improving the detection of radiological materials in maritime environments. Interested vendors are encouraged to submit their technical specifications and compliance information by May 15, 2025, and can direct inquiries to William Grimm at william.grimm@hq.dhs.gov or by phone at 202-601-9823.
Request for Information (RFI) for Graphic Building Wraps
Buyer not available
The Department of Health and Human Services (HHS) is seeking industry input through a Request for Information (RFI) regarding the potential use of graphic building wraps to promote the "Make America Healthy Again" initiative on the Hubert H. Humphrey (HHH) Building in Washington, D.C. The objective is to gather information on the feasibility, available options, structural impacts, installation and removal processes, necessary approvals, and associated costs related to implementing graphic wraps on this historic building, which is listed on the National Register of Historic Places. This initiative aims to enhance public health awareness and engage industry partners in promoting a healthier America. Interested parties must submit their responses to Azeb Mengistu at azeb.mengistu@hhs.gov by 1:00 PM on April 28, 2025, to be considered for this opportunity.
RRPV Solicitation Summary: Central Influenza and Emerging Infectious Diseases Vaccine Immunogenicity Laboratory Services
Buyer not available
The Department of Health and Human Services, through the Biomedical Advanced Research and Development Authority (BARDA), is seeking proposals for the establishment of a Central Influenza and Emerging Infectious Diseases Vaccine Immunoassay Laboratory. This initiative aims to enhance national health security by facilitating the rapid development of vaccines in response to potential pandemics, with a focus on conducting immunoassays to support vaccine research and clinical trials. The successful offeror will play a critical role in strengthening biodefense infrastructure by providing standardized laboratory services, with proposals due by May 30, 2025, and questions accepted until April 24, 2025. Interested parties can contact Rebecca Harmon at rebecca.harmon@ati.org for further information.